Spain· ES:1151061001IP1
GENVOYA 150mg/150mg/200mg/10mg COMPRIMIDOS RECUBIERTOS CON PELICULA
A medicinal product containing elvitegravir + cobicistat + emtricitabina + tenofovir alafenamida, registered in Spain by Gilead Sciences Ireland Unlimited Company.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- elvitegravir + cobicistat + emtricitabina + tenofovir alafenamida
- Manufacturer
- Gilead Sciences Ireland Unlimited Company
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Elvitegravir + cobicistat + emtricitabina + tenofovir alafenamida in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandGenvoyaGilead Sciences Ireland UC
- CzechiaGENVOYAGilead Sciences Ireland UC, Carrigtohill
- NorwayGenvoyaAbacus Medicine A/S
- United KingdomGenvoya 150mg/150mg/200mg/10mg tabletsGilead Sciences Ltd
- IcelandGenvoyaGilead Sciences Ireland UC*
- IrelandGenvoya 150 mg/150 mg/200 mg/10 mg film-coated tabletsGilead Sciences Ireland UC
- SwedenGenvoya 150 mg/150 mg/200 mg/10 mg Filmdragerad tablettGilead Sciences Ireland UC
- United StatesGenvoyaGilead Sciences, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Genvoya
- Liechtenstein · Genvoya
- Norway · Genvoya
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2254f4dd-723e-494a-94d8-7ce37a5b673d GET /v1/drugs/2254f4dd-723e-494a-94d8-7ce37a5b673d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Diagnóstico Hospitalario",
"estado": "{\"aut\":1790186523000}",
"nregistro": "1151061001IP1",
"substance": "elvitegravir + cobicistat + emtricitabina + tenofovir alafenamida"
}See everything about elvitegravir + cobicistat + emtricitabina + tenofovir alafenamida.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.